Compounds > r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid
Page last updated: 2024-09-03

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloid Deposits

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with Amyloid Deposits in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cookson, L; Lukas, MA; Millns, H; Richards, D1
Pepys, MB; Pepys-Vered, ME1

Trials

1 trial(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloid Deposits

ArticleYear
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
    Orphanet journal of rare diseases, 2022, 07-09, Volume: 17, Issue:1

    Topics: Amyloidosis; Carboxylic Acids; Follow-Up Studies; Humans; Plaque, Amyloid; Pyrrolidines; Serum Amyloid P-Component

2022

Other Studies

1 other study(ies) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloid Deposits

ArticleYear
Targeted treatment for amyloidosis.
    The Israel Medical Association journal : IMAJ, 2014, Volume: 16, Issue:5

    Topics: Amyloid; Amyloidosis; Carboxylic Acids; Disease Management; Genetic Therapy; Humans; Molecular Targeted Therapy; Plaque, Amyloid; Prealbumin; Protein Stability; Pyrrolidines; Sequestering Agents; Serum Amyloid A Protein; Serum Amyloid P-Component

2014